讲授的课程包括医学五年制人体寄生虫学理论课，医学五年制病原生物学实验课，医学八年制病原生物学实验课等。2021年在华西基础医学与法医学院青年教师教学竞赛中获得三等奖。参与四川大学《人体寄生虫学》慕课的录制工作，该慕课已于2022年在中国大学MOOC上线，深受学生喜爱。参编科学出版社《人体寄生虫学》第三版教材，以及四川大学出版社《病原生物学实验指导》教材。

项目：

1. 2022~2024主持国家自然科学基金青年基金项目：营养不良影响T细胞耗竭PD-1/PD-L1通路促进利什曼病的免疫机制研究，30万元。

2. 2021~2022主持四川大学专职博士后研发基金项目：机体营养状况对T细胞耗竭PD-1/PD-L1通路的影响及免疫机制研究，12.8万元。

文章：以第一作者或共同第一作者发表SCI论文9篇

1. Jinlei He, Fan Huang, Xuechun Liao, et al. TLR9 agonist CpG ODN 2395 promotes the immune response against Leishmania donovani in obesity and undernutrition mice. Acta Tropica, 2023, 242: 106921.

2. Jinlei He, Fan Huang, Jianhui Zhang, et al. Vaccine design based on 16 epitopes of SARS-CoV-2 spike protein. Journal of Medical Virology, 2021, 93(4): 2115-2131.

3. Jinlei He, Fan Huang, Jianhui Zhang, et al. DNA prime-protein boost vaccine encoding HLA-A2, HLA-A24 and HLA-DR1 restricted epitopes of CaNA2 against visceral leishmaniasis. Immunology, 2019, 156(1): 94-108.

4. Jinlei He, Fan Huang, Jiao Li, et al. Bioinformatics analysis of four proteins of Leishmania donovani to guide epitopes vaccine design and drug targets selection. Acta Tropica, 2019, 191: 50-59.

5. Jinlei He, Fan Huang, Han Chen, et al. Recombinant Mip-PilE-FlaA dominant epitopes vaccine candidate against Legionella pneumophila. Immunology Letters, 2017, 186: 33-40.

6. Jinlei He, Junrong Zhang, Yanxia He, et al. Construction of recombinant Mip-FlaA dominant epitope vaccine against Legionella pneumophila and evaluation of the immunogenicity and protective immunity. Immunologic Research, 2016, 64(1): 272-279.

7. Zhiwan Zheng#, Jinlei He#, Tao Luo, et al. Mutation characteristics and phylogenetic analysis of five Leishmania clinical isolates. Animals (Basel), 2022, 12(3): 321.

8. Jianhui Zhang#, Jinlei He#, Xuechun Liao, et al. Development of dominant epitope-based vaccines encoding Gp63, Kmp-11 and Amastin against visceral leishmaniasis. Immunobiology, 2021, 226(3): 152085.

9. Jianhui Zhang#, Jinlei He#, Jiao Li, et al. The immunogenicity and protective immunity of multi-epitopes DNA prime-protein boost vaccines encoding Amastin-Kmp-11, Kmp11-Gp63 and Amastin-Gp63 against visceral leishmaniasis. PLoS One, 2020, 15(3): e0230381.